Daves, Nathaniela .
HRN: 23-78-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
CEFUROXIME 750MG (VIAL)
04/26/2024
05/02/2024
IV
250mg
Q8h
Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes